EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Beyond Negative Regulation: IL‐1R8 and IL‐1R2 as Novel Immune Checkpoints

Domenico Supino iD, Roberto Garuti iD, Cecilia Garlanda iD

European Journal of Immunology · 2025-09 · 55 (9)

DOI: 10.1002/eji.70050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 05.09.2025. Verfasst von Domenico Supino und 2 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Receptors, Interleukin-1 Type II. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union-Next Generation, Ministry of University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL‐1 family members and their signaling receptors are key drivers of inflammation in sterile or infectious conditions, as well as polarization of the innate and adaptive immunity. Deregulated or excessive activation of the IL‐1 system is associated with detrimental inflammatory reactions. Beside signaling receptors, IL‐1‐family receptors comprise decoy or negative regulatory receptors, which regulate cell activation mediated by IL‐1 family ligands. IL‐1 ‐ family negative regulatory receptors, which include IL‐1R8 and IL‐1R2, have peculiar structural features and functions essential to the self‐regulation of the IL‐1 system. IL‐1R8 and IL‐1R2 emerge as regulatory molecules whose function is context‐dependent, spanning from negative regulation of inflammation in infections or conditions of sterile inflammation and cell damage, including cancer‐related inflammation, to skewing of myeloid and lymphoid cells, modulation of anti‐tumor immunity, and immune checkpoint activity. This review reports new insights into the physio‐pathological roles of these two negative regulatory IL‐1 family members, emphasizing their mechanisms of action and potential for innovative therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Interleukin-1 Type IIHumansAnimalsInflammationNeoplasmsSignal Transduction

Stichwörter der Autor:innen

cytokinesinflammationinhibitory receptorsinnate immunity

Substanzen

Receptors, Interleukin-1 Type II

Autor:innen und Institutionen

  • IRCCS Humanitas Research Hospital, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.

ORCID-Profile: Domenico Supino, Roberto Garuti, Cecilia Garlanda

Förderung

  • European Union-Next Generation
  • Ministry of University and Research

Zitieren

APA

Supino, D., Garuti, R., & Garlanda, C. (2025). Beyond Negative Regulation: IL‐1R8 and IL‐1R2 as Novel Immune Checkpoints. European Journal of Immunology, 55(9). https://doi.org/10.1002/eji.70050

Vancouver

Supino D, Garuti R, Garlanda C. Beyond Negative Regulation: IL‐1R8 and IL‐1R2 as Novel Immune Checkpoints. European Journal of Immunology. 2025;55(9). doi:10.1002/eji.70050

BibTeX
@article{Supino2025,
  author = {Supino, Domenico and Garuti, Roberto and Garlanda, Cecilia},
  title = {Beyond Negative Regulation: IL‐1R8 and IL‐1R2 as Novel Immune Checkpoints},
  journal = {European Journal of Immunology},
  year = {2025},
  volume = {55},
  number = {9},
  doi = {10.1002/eji.70050}
}
Kostenlos starten →